Takeda Pharmaceutical Co. Ltd


in

Takeda Pharmaceutical Co. Ltd. reported earnings results for the first quarter ended June 2008. The company posted sales of ¥396,881 million, up 8.3% from a year before, for an operating loss of ¥27,176 million, a turnaround from a year-before profit of ¥153,121 million, and a recurring loss of ¥6,388 million, against a profit of ¥190,444 million. Net profit came to ¥2,494 million, down 98.1%. The operating and recurring losses were due to the cost of buying Millennium Pharmaceuticals and acquiring full control of the U.S. joint venture.